Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-830-0 | CAS number: 100-21-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The acute oral LD50 of the substance was found to be >15380 mg/kg bw in the rat. The acute inhalation toxicity is also low, with a 2-hour LC50 of >2.02 mg/L. Low acute dermal toxicity indicated in a limit test in rabbits.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- No information; study reported in 1975
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Older, proprietary and guideline-comparable study pre-dating the introduction of GLP
- Qualifier:
- no guideline followed
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Principles of method if other than guideline:
- Standard acute oral toxicity study method comparable to OECD 401, but performed prior to the adoption of this guideline
- GLP compliance:
- not specified
- Remarks:
- : older study, pre-dates GLP
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- not specified
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Male and female albino rats
- Route of administration:
- oral: unspecified
- Vehicle:
- corn oil
- Details on oral exposure:
- Terephthalic acid was administered orally to rats as a 40% (w/v) homogenous suspension in corn oil
- Doses:
- 6834, 10250, and 15380 mg/kg bw.
- No. of animals per sex per dose:
- 5 rats per sex per dose
- Control animals:
- no
- Details on study design:
- The test substance was administered orally at three dose levels to groups of 5 male and 5 female albino rats. Rats were observed for clinical signs and mortality for 14 days post administration. Necropsy was performed on all rats that died during the test, and on all surviving rats at the end of the 14 day observation period. Body weights were recorded on test days 0 and 14.
- Statistics:
- Not applicable - not required
- Preliminary study:
- Not applicable
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 15 380 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: No deaths at the highest dose level
- Mortality:
- The only deaths that occurred were in the mid dose group (10250 mg/kg); 1 female died within 22 hours of administration, and 1 male died on day 3.
- Clinical signs:
- other: Clinical signs observed at all dose levels included hypoactivity, ruffled fur, diarrhoea, muscular weakness and rhinitis
- Gross pathology:
- The two rats that died before the end of the study were found to have pale discoloured kidneys at necropsy. Examination of the rats surviving to the end of the 14 day observation period did not reveal any gross pathologic alterations.
- Other findings:
- No other findings reported.
- Interpretation of results:
- not classified
- Remarks:
- Migrated informationCriteria used for interpretation of results: EU
- Conclusions:
- The acute oral LD50 of terephthalic acid in rats is greater than 15380 mg/kg bw.
- Executive summary:
Terephthalic acid in corn oil was administered orally by gavage to male and female rats at dose levels of 6834, 10250 and 15380 mg/kg bw. Rats were observed for 14 days following administration. The only deaths that occurred were in the mid dose group (10250 mg/kg bw); 1 female died within 22 hours of administration, and 1 male died on day 3. Gross necropsy revealed that these rats had pale discoloured kidneys. Clinical signs observed at all dose levels included hypoactivity, piloerection, diarrhoea, muscular weakness and rhinitis. Minimal transient weight loss was observed in individual animals; however there were no effects on body weight gain over the 14-day study period. Gross necropsy of all animals surviving to the end of the 14-day observation period did not reveal any abnormalities. The acute oral LD50 of terephthalic acid in the rat is therefore shown to be >15380 mg/kg bw under the conditions of this study.
Reference
The onset and recovery of clinical signs observed in rats following oral administration with terephthalic acid is shown below.
Clinical signs |
Dose level of terephthalic acid (mg/kg bw) |
|||||
6834 |
10250 |
15380 |
||||
Onset |
Recovery |
Onset |
Recovery |
Onset |
Recovery |
|
Hypoactivity |
6-22 h |
3 d |
30 m |
6 d |
30 m |
7 d |
Ruffled fur |
6-22 h |
3 d |
30 m |
6 d |
30 m |
6 d |
Diarrhoea |
6-22 h |
2 d |
6-22 h |
4 d |
1 h |
5 d |
Muscular weakness |
6-22 h |
2 d |
6-22 h |
5 d |
6-22 h |
5 d |
Rhinitis |
- |
- |
2 d |
6 d |
6-22 h |
6 d |
d =days, h =hours, m =minutes
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 15 380 mg/kg bw
- Quality of whole database:
- One proprietary study is available for acute oral toxicity. The study pre-dates GLP and the OECD guideline, but is comparable to OECD 401 and considered to be sufficiently reliable for the purposes of hazard classification.
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- No information available: study reported in 1987
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Proprietary non-GLP study, similar to OECD guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Deviations:
- yes
- Remarks:
- : target exposure time of 4 hours was not achieved due to technical difficulties
- Principles of method if other than guideline:
- The methodology was similar to OECD 403 (limit test), the test concentration was 2 mg/l and the exposure period was 2 hours (the target concentration had been 5 mg/l and target exposure time 4 hours).
- GLP compliance:
- no
- Remarks:
- : study pre-dates mandatory GLP
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Male and female Sprague-Dawley rats weighing approximately 135 g on arrival. The rats were purchased from Charles River Breeding Laboratories, Inc. MI. All rats were acclimatised for approximately 1 week and examined carefully to ensure their health and suitability as test subjects. Individuals were identified by metal ear tags.Purina Rodent Chow 5001 (Ralston Purina Co.) and reverse-osmosis purified water were available ad libitum, except during the exposure period.During acclimatisation and the post-exposure observation periods, the rats were housed individually in suspended stainless steel cages with deotized animal cage boards beneath the cages (except during exposure). Air conditioned animal rooms were maintained at approximately 22°C and 40% relative humidity. Fluorescent lighting was provided on a 12 hour light/dark cycle. Rats were randomly selected for testing and assigned to a single group.
- Route of administration:
- inhalation: dust
- Type of inhalation exposure:
- whole body
- Vehicle:
- other: unchanged (no vehicle)
- Details on inhalation exposure:
- The rats were exposed for 2 hours to a particulate aerosol, generated from a single batch of the test article. The target concentration was 5 mg/L and the target exposure duration was 4 hours. The generator was a dry materials feeder. The test article was transported from a reservoir, by a rotating helix, to the generator outlet where it was blown by a Transvector Jet into the exposure chamber. The 68.2 litre chamber was made of glass, with a removable Plexiglass lid. The test article aerosol entered the chamber through a port near the top of one end of the chamber and exited through a pipe placed near the bottom of the chamber on the opposite side. The chamber exhaust was vented through a charcoal filter. A California-type fume hood enclosed the entire generation and exposure system. An attempt to determine the particle size, using a Mercer Cascade Impactor was made during the exposure. However, the quantity and nature of test article produced in the chamber contributed to a malfunction of the of the Mercer Cascade Impactor, therefore particle size could not be determined. The test article accumulated in the chamber during exposure such that the exposure was terminated after 2 hours.The average chamber temperature was 21°C, with a relative humidity of 40%.
- Analytical verification of test atmosphere concentrations:
- yes
- Remarks:
- The achieved concentration was measured gravimetrically by drawing a known volume of the test atmosphere across an open-face filter and dividing the weight of the test article collected by the sample volume.
- Duration of exposure:
- 2 h
- Remarks on duration:
- Exposure was terminated prematurely due to technical difficulties
- Concentrations:
- The gravimetric time weighted average concentration was 2.02 mg/L, uncorrected for respirable particle size.
- No. of animals per sex per dose:
- 5 males and 5 females
- Control animals:
- no
- Details on study design:
- Rats were observed during exposure, approximately 1-1/4 and 4 hours after exposure, and at least once per day for the remainder of the 14 day observation period. All rats were weighed prior to the exposure, weekly thereafter, and immediately prior to necropsy. All rats were sacrificed and necropsied at the end of the 14 day observation period.
- Statistics:
- Formal statistical analysis was not required.
- Preliminary study:
- No preliminary results available.
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 2.02 mg/L air (analytical)
- Based on:
- test mat.
- Exp. duration:
- 2 h
- Remarks on result:
- other: Time Weighted Average concentration
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 1.01 mg/L air (analytical)
- Based on:
- test mat.
- Exp. duration:
- 4 h
- Remarks on result:
- other: Extrapolated from 2-hour exposure
- Mortality:
- There were no mortalities.
- Clinical signs:
- other: Diarrhoea, redness around the nose, wet/discoloured inguinal and abdominal fur and hairloss were observed during the study.
- Body weight:
- The mean initial body weights of the male and female rats were 198 g and 167 g, respectively. All rats gained weight progressively during the study.
- Gross pathology:
- All tissues examined in seven of the rats were within normal limits. Gross necropsy findings in the remaining three animals consisted of dark lungs in one male and enlarged mandibular lymph nodes in another male and female.
- Other findings:
- The test article accumulated on and around the rats during the exposure. All rats were covered with the test article when removed from the chamber, therefore each rat was rinsed with warm water following exposure.
- Interpretation of results:
- not classified
- Remarks:
- Migrated informationCriteria used for interpretation of results: EU
- Conclusions:
- Based on the results of the study, it was concluded that the LC50 in male and female rats was greater than 2.02 mg/L.
- Executive summary:
Purified terephthalic acid was administered as a particulate aerosol by inhalation to a group of 5 male and 5 female Sprague-Dawley rats (whole-body exposure). The rats were exposed to an achieved concentration of 2.02 mg/L for 2 hours; exposure was terminated prematurely due to an accumulation of the test material in the exposure equipment. No deaths occurred. Signs of toxicity (diarrhoea, redness around the nose, wet/discoloured inguinal and abdominal fur and hairloss) were observed during the study. Weight gain was unaffected by treatment. Gross necropsy revealed dark lungs in three rats. The acute (2 -hour) inhalation LC50 of terephthalic acid was found to be >2.02 mg/L. By extrapolation, the 4 -hour LC50 is estimated to be >1.01 mg/L.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LC50
- Value:
- 2 020 mg/m³ air
- Quality of whole database:
- A guideline-comparable study is supported by less reliable data.
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 19 April to 4 May 1990
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Proprietary study, methodology similar to OECD guidelines
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Qualifier:
- according to guideline
- Guideline:
- other: "Method of Testing Toxic Substances", Federal Register, Part 191 (1961)
- GLP compliance:
- not specified
- Remarks:
- no certificate/statement of compliance included in report
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rabbit
- Strain:
- New Zealand White
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Male and female New Zealand albino rabbits, approximately 2 months of age, purchased from Johnson Rabbit Ranch (Wilkinson, IN). The rabbits weighed 1.6-2.4 kg on arrival, and were acclimatised for approximately 4 weeks during which time they were examined to ensure their health and suitability as test subjects. Selected rabbits were identified by metal ear tags and corresponding cage cards.Each rabbit was provided with approximately 150 g of Purina Lab Rabbit Chow HF #5326 (Ralston Purina Co., MO) daily. Reverse osmosis-purified water was supplied ad libitum by means of an automatic watering system.The rabbits were housed individually in stainless steel cages. Poly pads were placed in the below the stainless steel mesh floor. The air-conditioned animal room was maintained at an average temperature and relative humidity of 23.7°C and 32%, respectively. Flurorescent lighting was provided on a 12 hour light/dark cycle.
- Type of coverage:
- occlusive
- Vehicle:
- water
- Remarks:
- test site pre-moistened with water
- Details on dermal exposure:
- The test article was applied undiluted. Individual doses were dispensed in glass vials.Approximately 24 hours prior to study initiation, the fur was clipped from an area of approximately 240 cm² on the back of each rabbit and the skin was examined for abnormalities. Care was taken to avoid abrading the animal's backs.The shaved application site was pre-moistened with water prior to application of the test substance. The test substance was covered with a 12.8 x 23.0 cm surgical dressing (Surgipad). The dressing was then covered by plastic film and secured by lint-free cloth and Elastoplast. The wrappings were removed after 24 hours and the skin was wiped gently with gauze and 0.9% saline to remove residual test article.
- Duration of exposure:
- 24 hours
- Doses:
- 2000 mg/kg bw.
- No. of animals per sex per dose:
- 5 rabbits/sex
- Control animals:
- not required
- Details on study design:
- Rabbits used in the study were selected at random and assigned to a single group of 5 males and 5 females. Prior to selection, the rabbits received a thorough physical examination to ensure their suitability for use.All rabbits were observed aproximately 3/4, 3-1/4, 4-1/4 and 5-1/4 hours after dosing and at least once per day for 14 days after removal of the wrappings. All test animals were weighed immediately prior to dosing and the weights used for dosage calculations. The rabbits were weighed 7 days after application and at study termination.All rabbits were euthanised at the end of the observation period by anaesthetic overdose. A limited gross necropsy was performed on all test animals.
- Statistics:
- Formal statistical analysis was not required.
- Preliminary study:
- A preliminary study was not conducted.
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: No mortality at the limit dose
- Mortality:
- No deaths occurred during the study.
- Clinical signs:
- other: Minor signs of dermal irritation (i.e. erythema) were observed within the appplication site of two male and four female rabbits immediately following unwrapping. The application site of all test animals was partially or completely masked by hair growth th
- Gross pathology:
- No abnormalities were detected at necropsy.
- Other findings:
- No other findings were reported.
- Interpretation of results:
- not classified
- Remarks:
- Migrated informationCriteria used for interpretation of results: EU
- Conclusions:
- The acute dermal LD50 of terephthalic acid was found to be greater than 2000 mg/kg bw under the conditions of this study.
- Executive summary:
The acute dermal toxicity of terephthalic acid was determined in a limit test, with five male and five female New Zealand White rabbits. The test material was placed in contact with the shaved pre-moistened skin of the rabbits, under an occlusive dressing, for 24 hours. The rabbits were observed during this time and for 14 days thereafter. No deaths occurred during the study. Mild dermal irritation (erythema) was observed within the application site of six rabbits immediately following unwrapping. Otherwise, no adverse treatment-related clinical signs were observed in any rabbits during the study. Mean body weights increased during the study. No gross pathological lesions attributable to treatment were evident in any of the rabbits at necropsy. The acute dermal LD50 of terephthalic acid was found to be greater than 2000 mg/kg bw under the conditions of this study.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- Reliable, guideline-compliant study
Additional information
Acute oral toxicity
A guideline-comparable study (Harrison, 1975) is available, in which terephthalic acid in corn oil was administered orally by gavage to male and female rats at dose levels of 6834, 10250 and 15380 mg/kg bw. Rats were observed for 14 days following administration. The only deaths that occurred were in the mid dose group (10250 mg/kg bw); 1 female died within 22 hours of administration, and 1 male died on day 3. Gross necropsy revealed that these rats had pale discoloured kidneys. Clinical signs observed at all dose levels included hypoactivity, piloerection, diarrhoea, muscular weakness and rhinitis. Minimal transient weight loss was observed in individual animals; however there were no effects on body weight gain over the 14-day study period. Gross necropsy of all animals surviving to the end of the 14-day observation period did not reveal any abnormalities. The acute oral LD50 of terephthalic acid in the rat is therefore shown to be >15380 mg/kg bw under the conditions of this study. Terepthalic acid is therefore of very low acute oral toxicity.
Acute inhalation toxicity
In the key study (Leach et al, 1987), purified terephthalic acid was administered as a particulate aerosol by inhalation to a group of 5 male and 5 female Sprague-Dawley rats. The rats were exposed (whole body) to an aerosol concentration of 2.02 mg/L for two hours; the exposure period was terminated due to an accumulation of the test material. No rats died during the study. Therefore, the 2 hour acute inhalation LC50 of purified terephthalic acid was estimated to be greater than 2.02 mg/L. Gross necropsy revealed 1 male rat with dark lungs, and 1 male and 1 female rat with enlarged mandibular lymph nodes. No other abnormalities were detected. The 2-hour LC50 was therefore >2.02 mg/L; a time-adjusted 4 -hour LC50 of >1.01 mg/L can therefore be derived.
In a further study, investigating toxicity from pyrotechnic dissemination Thomson et al (1988), male F344 rats were exposed to pyrotechnically disseminated terephthalic acid in nose-only exposure chambers for 30 minutes. Nominal terephthalic acid concentrations were 100, 200 and 400 mg/m3. Two control groups were exposed to either air alone, or the fuse/fuel mix alone. Rats underwent pulmonary function tests and bronchoalveolar lavage immediately prior to sacrifice, at 24 hours or 14 days post exposure. There were no compound-related mortalities. There were no adverse changes in pulmonary function, lavage or histopathology. The only adverse reaction observed was a dose-related rhinorrhea that disapeared within 1 hour post exposure. There was no toxic effects of the combustion byproducts (CO, CO2, NO2 and SO2), which remained below the threshold limit value. Under the conditions of this study, the acute LC50 of TPA was greater than 235 mg/m3 (analytical concentration).
A further study (ICI, 1987) is available only as a secondary source but reports no treatmnet-related effects in groups of 10 male rats exposed to terephthalic acid at target concentrations of 30, 100 or 1000 mg/m3; these findings are consistent with the results of the other studies.
While the studies of acute inhalation toxicity available for terephthalic acid have some deficiencies, they are consistent in demonstrating low toxicity by this route of exposure.
Acute dermal toxicity
The acute dermal toxicity of the substance in the rabbit was investigated by Lord (1990) in a limit test, with five male and five female New Zealand White rabbits. The test material was placed in contact with the shaved pre-moistened skin of the rabbits, under an occlusive dressing, for 24 hours. The rabbits were observed during this time and for 14 days thereafter. No deaths occurred during the study. Mild dermal irritation (erythema) was observed within the application site of six rabbits immediately following unwrapping. Otherwise, no adverse treatment-related clinical signs were observed in any rabbits during the study. Mean body weights increased during the study. No gross pathological lesions attributable to treatment were evident in any of the rabbits at necropsy. The acute dermal LD50 of terephthalic acid was found to be greater than 2000 mg/kg bw under the conditions of this study.
Justification for selection of acute toxicity – oral endpoint
Only study available for this endpoint
Justification for selection of acute toxicity – inhalation endpoint
Guideline-comparable study
Justification for selection of acute toxicity – dermal endpoint
Only study available for this endpoint
Justification for classification or non-classification
No classification for acute toxicity is proposed on the basis of the acute oral and dermal toxicity studies. The available data also demonstrate low acute inhalation toxicity and indicate that the substance would not be classified for acute inhalation toxicity. Although the available inhalation toxicity studies use exposure periods shorter than the standard 4 hours and/or lower maximum exposure concentrations than the limits for classification, no further inhalation toxicity testing is proposed. It can be reliably assumed, based on the available lack of effects at exposure concentration of approximately 1 and 2 mg/L that the inhalation LC50 of the substance will be below the limit for classification of 5 mg/L. Additional testing is not considered to be appropriate on scientific grounds and for reasons of animal welfare.
No classification for acute toxicity is therefore proposed, according to the CLP Regulation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.